Khetam Habeeb Rasool

Dr. Khetam Habeeb Rasool


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Nanotechnology Reviews
Verified
Journal Article
Open access
PDF file
HKHussam H. Kadhum
Hussam H. Kadhum
SISumayah Ibraheem
Sumayah Ibraheem
ZJZainab Nizar Jawad
Zainab Nizar Jawad
ZJZuhair Mohammed Ali Jeddoa
Zuhair Mohammed Ali Jeddoa
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
Ayman Abdel Aziz SwelumAyman Abdel Aziz Swelum
Ayman Abdel Aziz Swelum
The use of plant extracts as potent reducing agents for the environmentally friendly production of nanoparticles (NPs) has recently attracted the interest of scientists. NPs have received high attention because of their novel properties. The aim of the present study is to biosynthesize zinc oxide nanoparticles (ZnO NPs) using Raphanus sativus and study their effect as antibacterial, anticancer, antiviral, and antidiabetic, agents, NLRP3 inflammasome inhibitors, and inducers of phagocytosis and autophagy. The antibacterial, anticancer, and antiviral activities of ZnO NPs were investigated using different assays: well diffusion assay, MTT assay, reverse transcription polymerase chain reaction, reactive oxygen species generation, and apoptosis assay. Meanwhile, immunofluorescent assay, enzyme-linked immunosorbent assay, and flow cytometry were used for detection of autophagy and phagocytosis. Docking was also achieved to study their binding mode as well as affinity within the target enzymes (glucosamine-6-phosphate synthase) (PDB:1MOQ) active site, estrogen receptor (PDB:3ERT) active site, and tubulin receptor (PDB:4O2B) active site. The results demonstrated that the ZnO NPs have an inhibitory role against bacteria and the proliferation of lung cancer cells (A549). IC 50 was 22.78 µg/mL for A549 cells. For MCF-10, was 272.24 µg/mL, antiviral activity against influenza virus, and antidiabetic agent. Conversely, the results showed the ability of ZnO NPs to reduce inflammasome activity via induction of autophagy. The study’s findings show that R. sativus can be easily and effectively used to synthesize ZnO NPs, and they also highlight the ZnO NPs’ considerable potential as antibacterial, antiviral, anticancer, NLRP3 inflammasome inhibitor, antidiabetic agent, and phagocytosis and autophagy inducer. Based on our findings, the green synthesized ZnO NPs could be used as promising therapeutic agents for biomedical applications.

1 January 2022 in Microbial Pathogenesis
Verified
Journal Article
Closed access
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
AAAlia Essam Mahmood Alubadi
Alia Essam Mahmood Alubadi
IAIbrahim Faisal Ibrahim Al-Bayati
Ibrahim Faisal Ibrahim Al-Bayati

31 October 2021 in Veterinary World
Verified
Journal Article
Open access
MJMarwa Mohammed Ali Jassim
Marwa Mohammed Ali Jassim
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
MMMajid Mohammed Mahmood
Majid Mohammed Mahmood
Background and Aim: The mutation in the wild-type tumor suppressor gene p53 is the most common genetic change in human tumors. In addition, the normal function of p21, which is both antiproliferative and an inhibitor of the cell cycle, is disrupted in some types of cancer. Meanwhile, cyclin D1 is a member of the cyclin protein family that is involved in regulating cell cycle progression. This study aimed to assess the expressions of the cell cycle inhibitory proteins p21, cyclin D1, and tumor suppressor gene p53, as well as their influence on the expressed histopathological changes in breast cancer tissues. Materials and Methods: Overall, 40 breast tissue specimens were investigated in this study, 30 of which were cancerous, while 10 were healthy tissues. p53, p21, and cyclin D1 expression patterns were detected using an immunohistochemistry (IHC) system. Results: The IHC reactions for p53 were positively observed in 27/30 (90%) cancerous tissues, compared with 2/10 (20%) normal breast tissues. For p21, reactions were observed in 28/30 (93.33%) cancerous tissues and 3/10 (30%) control tissues. For cyclin DI, reactions were observed in 25/30 (83.33%) cancerous tissues and 1/10 (10%) control tissues. The differences between the breast cancer tissues and the control tissues were statistically highly significant (p<0.01). Conclusion: The high expression rates of p21, cyclin D1, and p53 in malignant breast cancer cells with little or no regulatory role might imply mutational events in these proteins operating in concert with a variety of other genetic mutations in these tissues, which may play a molecular role in the development and/or progression of breast carcinogenesis.

1 August 2017 in Microbial Pathogenesis
Verified
Journal Article
Closed access
LMLikaa Mahdi
Likaa Mahdi
HMHadeel Musafer
Hadeel Musafer
LZLuma Zwain
Luma Zwain
ISIstabreq Salman
Istabreq Salman
IAIkbal Al-Joofy
Ikbal Al-Joofy
NTNehad Taher
Nehad Taher

10 May 2025 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
PRPaul Rodrigues
Paul Rodrigues
AAAbdulrahman T. Ahmed
Abdulrahman T. Ahmed
MJMajid Jabir
Majid Jabir
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
SMSoumya V. Menon
Soumya V. Menon
SASalah Hassan Zain Al-Abdeen
Salah Hassan Zain Al-Abdeen

21 June 2023 in Reviews and Research in Medical Microbiology
Verified
Journal Article
Closed access
SHSeror A. Abdul Hussien
Seror A. Abdul Hussien
KRKhetam Habeeb Rasool
Khetam Habeeb Rasool
NZNeihaya H. Zaki
Neihaya H. Zaki
Escherichia coli prolidase play a role analogous to that of human prolidase – the breakdown of dipeptides stemming from protein catabolism – or an additional, regulatory role. The aim of the study was to determine the effect of purified prolidase on cancer cells and many immunological aspects. About 100 samples were collected from infant stool to isolate E. coli bacteria. Ion exchange and gel filtration chromatography were used in purification of prolidase enzyme with specific activity (2 U/ml) and (6.6 U/mg) protein. Molecular weight for prolidase from E. coli (MS12) found to be 20 kDa. Cytotoxicity effect of prolidase were determined and the IC50 to the MCF-7 was 65.1 μg/ml, while IC50 of WRL-68 was 148.3 μg/ml. In addition to that, prolidase at concentration of 200 μg/ml has showed significant effect on multiparameters (cell viability, nuclear intensity, mitochondrial membrane potential (MMP), membrane permeability, and cytochrome C release). Caspase (8 and 9) and reactive oxygen species activity increased significantly by increasing prolidase concentration in MCF-7 cell line. Antioxidant activity of purified prolidase was demonstrated and DPPH-reducing activity rose as the concentration of the enzyme was increased. There was no significant change in white blood cell total and differential accounts after 14 days in comparison with control count when injected with different concentrations of the prolidase. Interleukin -1β, Interleukin- 8 and tumor necrotic factor- α levels were increased significantly with P value (0.001) in compared to control, depending on prolidase concentration. Phagocytic mechanism exhibited highest activity level (80%) when highest concentration (500 μg/ ml) of enzyme with G+ ve bacteria. The aim of the study was determine the effect of purified prolidase on cancer cells and many immunological aspects.